nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRB2—ulcerative colitis	0.451	1	CbGaD
Asenapine—CYP3A4—Budesonide—ulcerative colitis	0.0227	0.159	CbGbCtD
Asenapine—HRH2—gastric juice—ulcerative colitis	0.0223	0.289	CbGeAlD
Asenapine—CYP1A2—Nicotine—ulcerative colitis	0.0188	0.132	CbGbCtD
Asenapine—CYP2D6—Nicotine—ulcerative colitis	0.0155	0.109	CbGbCtD
Asenapine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0139	0.0975	CbGbCtD
Asenapine—HTR7—enteric nervous system—ulcerative colitis	0.012	0.156	CbGeAlD
Asenapine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0101	0.071	CbGbCtD
Asenapine—CYP3A4—Nicotine—ulcerative colitis	0.00987	0.0691	CbGbCtD
Asenapine—HTR7—myenteric nerve plexus—ulcerative colitis	0.00912	0.118	CbGeAlD
Asenapine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00885	0.062	CbGbCtD
Asenapine—CYP3A4—Triamcinolone—ulcerative colitis	0.00767	0.0538	CbGbCtD
Asenapine—HTR2A—enteric nervous system—ulcerative colitis	0.00751	0.0975	CbGeAlD
Asenapine—CYP3A4—Betamethasone—ulcerative colitis	0.00658	0.0461	CbGbCtD
Asenapine—CYP3A4—Prednisolone—ulcerative colitis	0.0065	0.0455	CbGbCtD
Asenapine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00616	0.0432	CbGbCtD
Asenapine—CYP3A4—Prednisone—ulcerative colitis	0.00613	0.043	CbGbCtD
Asenapine—CYP2D6—Dexamethasone—ulcerative colitis	0.00602	0.0422	CbGbCtD
Asenapine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00569	0.0739	CbGeAlD
Asenapine—CYP3A4—Dexamethasone—ulcerative colitis	0.00383	0.0268	CbGbCtD
Asenapine—UGT1A4—digestive system—ulcerative colitis	0.00217	0.0281	CbGeAlD
Asenapine—UGT1A4—liver—ulcerative colitis	0.00161	0.021	CbGeAlD
Asenapine—HRH2—digestive system—ulcerative colitis	0.00136	0.0176	CbGeAlD
Asenapine—HTR2B—smooth muscle tissue—ulcerative colitis	0.00102	0.0133	CbGeAlD
Asenapine—HRH2—liver—ulcerative colitis	0.00101	0.0131	CbGeAlD
Asenapine—HTR7—epithelium—ulcerative colitis	0.000908	0.0118	CbGeAlD
Asenapine—ADRA1A—epithelium—ulcerative colitis	0.000876	0.0114	CbGeAlD
Asenapine—HTR7—smooth muscle tissue—ulcerative colitis	0.000875	0.0114	CbGeAlD
Asenapine—SLC6A4—digestive system—ulcerative colitis	0.000814	0.0106	CbGeAlD
Asenapine—HTR2B—digestive system—ulcerative colitis	0.000807	0.0105	CbGeAlD
Asenapine—HTR7—digestive system—ulcerative colitis	0.000691	0.00897	CbGeAlD
Asenapine—HRH1—epithelium—ulcerative colitis	0.000678	0.00881	CbGeAlD
Asenapine—ADRA1A—lymphoid tissue—ulcerative colitis	0.000675	0.00876	CbGeAlD
Asenapine—HRH1—smooth muscle tissue—ulcerative colitis	0.000653	0.00848	CbGeAlD
Asenapine—HTR2A—epithelium—ulcerative colitis	0.000566	0.00735	CbGeAlD
Asenapine—CYP1A2—digestive system—ulcerative colitis	0.000551	0.00716	CbGeAlD
Asenapine—HTR2A—smooth muscle tissue—ulcerative colitis	0.000546	0.00709	CbGeAlD
Asenapine—HRH1—digestive system—ulcerative colitis	0.000516	0.0067	CbGeAlD
Asenapine—HTR7—liver—ulcerative colitis	0.000515	0.00668	CbGeAlD
Asenapine—ADRA1A—liver—ulcerative colitis	0.000496	0.00645	CbGeAlD
Asenapine—ADRA2C—liver—ulcerative colitis	0.000473	0.00614	CbGeAlD
Asenapine—HTR2A—digestive system—ulcerative colitis	0.000431	0.0056	CbGeAlD
Asenapine—CYP1A2—liver—ulcerative colitis	0.00041	0.00533	CbGeAlD
Asenapine—CYP3A4—digestive system—ulcerative colitis	0.000399	0.00518	CbGeAlD
Asenapine—CYP2D6—digestive system—ulcerative colitis	0.000392	0.0051	CbGeAlD
Asenapine—HTR2A—liver—ulcerative colitis	0.000321	0.00417	CbGeAlD
Asenapine—CYP3A4—liver—ulcerative colitis	0.000297	0.00386	CbGeAlD
Asenapine—CYP2D6—liver—ulcerative colitis	0.000292	0.0038	CbGeAlD
Asenapine—Weight increased—Methylprednisolone—ulcerative colitis	0.000283	0.00146	CcSEcCtD
Asenapine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000281	0.00144	CcSEcCtD
Asenapine—Nausea—Nicotine—ulcerative colitis	0.000281	0.00144	CcSEcCtD
Asenapine—Fatigue—Budesonide—ulcerative colitis	0.000281	0.00144	CcSEcCtD
Asenapine—Hypertension—Mesalazine—ulcerative colitis	0.00028	0.00144	CcSEcCtD
Asenapine—Constipation—Budesonide—ulcerative colitis	0.000279	0.00143	CcSEcCtD
Asenapine—Psychotic disorder—Prednisone—ulcerative colitis	0.000279	0.00143	CcSEcCtD
Asenapine—Arthralgia—Mesalazine—ulcerative colitis	0.000276	0.00142	CcSEcCtD
Asenapine—Anxiety—Mesalazine—ulcerative colitis	0.000275	0.00141	CcSEcCtD
Asenapine—Irritability—Prednisone—ulcerative colitis	0.000272	0.0014	CcSEcCtD
Asenapine—Hypotension—Azathioprine—ulcerative colitis	0.000272	0.0014	CcSEcCtD
Asenapine—Dry mouth—Mesalazine—ulcerative colitis	0.00027	0.00139	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000265	0.00136	CcSEcCtD
Asenapine—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000265	0.00136	CcSEcCtD
Asenapine—Shock—Mesalazine—ulcerative colitis	0.000261	0.00134	CcSEcCtD
Asenapine—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000261	0.00134	CcSEcCtD
Asenapine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00026	0.00133	CcSEcCtD
Asenapine—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000259	0.00133	CcSEcCtD
Asenapine—Tachycardia—Mesalazine—ulcerative colitis	0.000259	0.00133	CcSEcCtD
Asenapine—Weight increased—Betamethasone—ulcerative colitis	0.000258	0.00132	CcSEcCtD
Asenapine—Weight increased—Dexamethasone—ulcerative colitis	0.000258	0.00132	CcSEcCtD
Asenapine—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000255	0.00131	CcSEcCtD
Asenapine—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000255	0.00131	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000252	0.00129	CcSEcCtD
Asenapine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000251	0.00129	CcSEcCtD
Asenapine—Eye disorder—Hydrocortisone—ulcerative colitis	0.000248	0.00127	CcSEcCtD
Asenapine—Hypotension—Mesalazine—ulcerative colitis	0.000248	0.00127	CcSEcCtD
Asenapine—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000245	0.00126	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000241	0.00124	CcSEcCtD
Asenapine—Hypersensitivity—Budesonide—ulcerative colitis	0.00024	0.00123	CcSEcCtD
Asenapine—Insomnia—Mesalazine—ulcerative colitis	0.00024	0.00123	CcSEcCtD
Asenapine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.00024	0.00123	CcSEcCtD
Asenapine—Dyspnoea—Mesalazine—ulcerative colitis	0.000236	0.00121	CcSEcCtD
Asenapine—Somnolence—Mesalazine—ulcerative colitis	0.000236	0.00121	CcSEcCtD
Asenapine—Asthenia—Budesonide—ulcerative colitis	0.000234	0.0012	CcSEcCtD
Asenapine—Dyspepsia—Mesalazine—ulcerative colitis	0.000233	0.0012	CcSEcCtD
Asenapine—Eye disorder—Methylprednisolone—ulcerative colitis	0.000233	0.0012	CcSEcCtD
Asenapine—Mental disorder—Hydrocortisone—ulcerative colitis	0.000232	0.00119	CcSEcCtD
Asenapine—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000231	0.00119	CcSEcCtD
Asenapine—Malnutrition—Hydrocortisone—ulcerative colitis	0.000231	0.00119	CcSEcCtD
Asenapine—Neutropenia—Prednisone—ulcerative colitis	0.000231	0.00118	CcSEcCtD
Asenapine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000229	0.00118	CcSEcCtD
Asenapine—Fatigue—Mesalazine—ulcerative colitis	0.000228	0.00117	CcSEcCtD
Asenapine—Constipation—Mesalazine—ulcerative colitis	0.000227	0.00116	CcSEcCtD
Asenapine—Angiopathy—Methylprednisolone—ulcerative colitis	0.000226	0.00116	CcSEcCtD
Asenapine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000225	0.00116	CcSEcCtD
Asenapine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000225	0.00115	CcSEcCtD
Asenapine—Weight increased—Prednisone—ulcerative colitis	0.000224	0.00115	CcSEcCtD
Asenapine—Hyperglycaemia—Prednisone—ulcerative colitis	0.000222	0.00114	CcSEcCtD
Asenapine—Depression—Prednisone—ulcerative colitis	0.000219	0.00113	CcSEcCtD
Asenapine—Mental disorder—Methylprednisolone—ulcerative colitis	0.000218	0.00112	CcSEcCtD
Asenapine—Malnutrition—Methylprednisolone—ulcerative colitis	0.000217	0.00111	CcSEcCtD
Asenapine—Angioedema—Prednisolone—ulcerative colitis	0.000216	0.00111	CcSEcCtD
Asenapine—Dizziness—Budesonide—ulcerative colitis	0.000215	0.00111	CcSEcCtD
Asenapine—Hypersensitivity—Azathioprine—ulcerative colitis	0.000214	0.0011	CcSEcCtD
Asenapine—Malaise—Prednisolone—ulcerative colitis	0.000213	0.00109	CcSEcCtD
Asenapine—Dysgeusia—Triamcinolone—ulcerative colitis	0.000213	0.00109	CcSEcCtD
Asenapine—Syncope—Prednisolone—ulcerative colitis	0.000212	0.00109	CcSEcCtD
Asenapine—Eye disorder—Betamethasone—ulcerative colitis	0.000212	0.00109	CcSEcCtD
Asenapine—Eye disorder—Dexamethasone—ulcerative colitis	0.000212	0.00109	CcSEcCtD
Asenapine—Angioedema—Hydrocortisone—ulcerative colitis	0.000211	0.00108	CcSEcCtD
Asenapine—Malaise—Hydrocortisone—ulcerative colitis	0.000208	0.00107	CcSEcCtD
Asenapine—Loss of consciousness—Prednisolone—ulcerative colitis	0.000208	0.00107	CcSEcCtD
Asenapine—Vomiting—Budesonide—ulcerative colitis	0.000207	0.00106	CcSEcCtD
Asenapine—Syncope—Hydrocortisone—ulcerative colitis	0.000207	0.00106	CcSEcCtD
Asenapine—Angiopathy—Betamethasone—ulcerative colitis	0.000206	0.00106	CcSEcCtD
Asenapine—Angiopathy—Dexamethasone—ulcerative colitis	0.000206	0.00106	CcSEcCtD
Asenapine—Rash—Budesonide—ulcerative colitis	0.000205	0.00106	CcSEcCtD
Asenapine—Dermatitis—Budesonide—ulcerative colitis	0.000205	0.00105	CcSEcCtD
Asenapine—Convulsion—Prednisolone—ulcerative colitis	0.000205	0.00105	CcSEcCtD
Asenapine—Headache—Budesonide—ulcerative colitis	0.000204	0.00105	CcSEcCtD
Asenapine—Hypertension—Prednisolone—ulcerative colitis	0.000204	0.00105	CcSEcCtD
Asenapine—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000203	0.00104	CcSEcCtD
Asenapine—Convulsion—Hydrocortisone—ulcerative colitis	0.0002	0.00103	CcSEcCtD
Asenapine—Hypertension—Hydrocortisone—ulcerative colitis	0.000199	0.00102	CcSEcCtD
Asenapine—Angioedema—Triamcinolone—ulcerative colitis	0.000199	0.00102	CcSEcCtD
Asenapine—Angioedema—Methylprednisolone—ulcerative colitis	0.000198	0.00102	CcSEcCtD
Asenapine—Malaise—Triamcinolone—ulcerative colitis	0.000196	0.00101	CcSEcCtD
Asenapine—Anxiety—Hydrocortisone—ulcerative colitis	0.000196	0.00101	CcSEcCtD
Asenapine—Malaise—Methylprednisolone—ulcerative colitis	0.000196	0.001	CcSEcCtD
Asenapine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000195	0.001	CcSEcCtD
Asenapine—Syncope—Triamcinolone—ulcerative colitis	0.000195	0.001	CcSEcCtD
Asenapine—Syncope—Methylprednisolone—ulcerative colitis	0.000195	0.000999	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—ulcerative colitis	0.000194	0.000996	CcSEcCtD
Asenapine—Nausea—Budesonide—ulcerative colitis	0.000194	0.000994	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000193	0.000991	CcSEcCtD
Asenapine—Dizziness—Azathioprine—ulcerative colitis	0.000192	0.000988	CcSEcCtD
Asenapine—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000191	0.000981	CcSEcCtD
Asenapine—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000191	0.000979	CcSEcCtD
Asenapine—Asthenia—Mesalazine—ulcerative colitis	0.00019	0.000977	CcSEcCtD
Asenapine—Shock—Prednisolone—ulcerative colitis	0.00019	0.000975	CcSEcCtD
Asenapine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000188	0.000968	CcSEcCtD
Asenapine—Convulsion—Triamcinolone—ulcerative colitis	0.000188	0.000967	CcSEcCtD
Asenapine—Tachycardia—Prednisolone—ulcerative colitis	0.000188	0.000967	CcSEcCtD
Asenapine—Convulsion—Methylprednisolone—ulcerative colitis	0.000188	0.000965	CcSEcCtD
Asenapine—Hypertension—Triamcinolone—ulcerative colitis	0.000188	0.000964	CcSEcCtD
Asenapine—Hypertension—Methylprednisolone—ulcerative colitis	0.000187	0.000962	CcSEcCtD
Asenapine—Shock—Hydrocortisone—ulcerative colitis	0.000185	0.000952	CcSEcCtD
Asenapine—Vomiting—Azathioprine—ulcerative colitis	0.000185	0.00095	CcSEcCtD
Asenapine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000185	0.000949	CcSEcCtD
Asenapine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000185	0.000949	CcSEcCtD
Asenapine—Eye disorder—Prednisone—ulcerative colitis	0.000184	0.000947	CcSEcCtD
Asenapine—Anxiety—Methylprednisolone—ulcerative colitis	0.000184	0.000945	CcSEcCtD
Asenapine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000184	0.000945	CcSEcCtD
Asenapine—Rash—Azathioprine—ulcerative colitis	0.000183	0.000942	CcSEcCtD
Asenapine—Dermatitis—Azathioprine—ulcerative colitis	0.000183	0.000941	CcSEcCtD
Asenapine—Headache—Azathioprine—ulcerative colitis	0.000182	0.000936	CcSEcCtD
Asenapine—Dry mouth—Triamcinolone—ulcerative colitis	0.000181	0.00093	CcSEcCtD
Asenapine—Angioedema—Dexamethasone—ulcerative colitis	0.00018	0.000926	CcSEcCtD
Asenapine—Angioedema—Betamethasone—ulcerative colitis	0.00018	0.000926	CcSEcCtD
Asenapine—Angiopathy—Prednisone—ulcerative colitis	0.000179	0.00092	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—ulcerative colitis	0.000178	0.000916	CcSEcCtD
Asenapine—Malaise—Dexamethasone—ulcerative colitis	0.000178	0.000914	CcSEcCtD
Asenapine—Malaise—Betamethasone—ulcerative colitis	0.000178	0.000914	CcSEcCtD
Asenapine—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000177	0.000911	CcSEcCtD
Asenapine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000177	0.000909	CcSEcCtD
Asenapine—Syncope—Dexamethasone—ulcerative colitis	0.000177	0.000909	CcSEcCtD
Asenapine—Syncope—Betamethasone—ulcerative colitis	0.000177	0.000909	CcSEcCtD
Asenapine—Hypotension—Hydrocortisone—ulcerative colitis	0.000176	0.000904	CcSEcCtD
Asenapine—Dizziness—Mesalazine—ulcerative colitis	0.000175	0.0009	CcSEcCtD
Asenapine—Shock—Triamcinolone—ulcerative colitis	0.000175	0.000897	CcSEcCtD
Asenapine—Insomnia—Prednisolone—ulcerative colitis	0.000175	0.000896	CcSEcCtD
Asenapine—Shock—Methylprednisolone—ulcerative colitis	0.000174	0.000895	CcSEcCtD
Asenapine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000174	0.000892	CcSEcCtD
Asenapine—Loss of consciousness—Betamethasone—ulcerative colitis	0.000173	0.00089	CcSEcCtD
Asenapine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000173	0.00089	CcSEcCtD
Asenapine—Tachycardia—Triamcinolone—ulcerative colitis	0.000173	0.000889	CcSEcCtD
Asenapine—Mental disorder—Prednisone—ulcerative colitis	0.000173	0.000888	CcSEcCtD
Asenapine—Nausea—Azathioprine—ulcerative colitis	0.000173	0.000888	CcSEcCtD
Asenapine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000173	0.000887	CcSEcCtD
Asenapine—Malnutrition—Prednisone—ulcerative colitis	0.000172	0.000882	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000172	0.000882	CcSEcCtD
Asenapine—Convulsion—Betamethasone—ulcerative colitis	0.000171	0.000878	CcSEcCtD
Asenapine—Convulsion—Dexamethasone—ulcerative colitis	0.000171	0.000878	CcSEcCtD
Asenapine—Insomnia—Hydrocortisone—ulcerative colitis	0.00017	0.000875	CcSEcCtD
Asenapine—Hypertension—Dexamethasone—ulcerative colitis	0.00017	0.000875	CcSEcCtD
Asenapine—Hypertension—Betamethasone—ulcerative colitis	0.00017	0.000875	CcSEcCtD
Asenapine—Vomiting—Mesalazine—ulcerative colitis	0.000168	0.000865	CcSEcCtD
Asenapine—Anxiety—Dexamethasone—ulcerative colitis	0.000167	0.00086	CcSEcCtD
Asenapine—Anxiety—Betamethasone—ulcerative colitis	0.000167	0.00086	CcSEcCtD
Asenapine—Rash—Mesalazine—ulcerative colitis	0.000167	0.000858	CcSEcCtD
Asenapine—Dermatitis—Mesalazine—ulcerative colitis	0.000167	0.000857	CcSEcCtD
Asenapine—Headache—Mesalazine—ulcerative colitis	0.000166	0.000853	CcSEcCtD
Asenapine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000166	0.000852	CcSEcCtD
Asenapine—Hypotension—Methylprednisolone—ulcerative colitis	0.000165	0.00085	CcSEcCtD
Asenapine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000163	0.000836	CcSEcCtD
Asenapine—Fatigue—Hydrocortisone—ulcerative colitis	0.000162	0.000834	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000162	0.00083	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000161	0.000828	CcSEcCtD
Asenapine—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000161	0.000827	CcSEcCtD
Asenapine—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000161	0.000827	CcSEcCtD
Asenapine—Insomnia—Triamcinolone—ulcerative colitis	0.00016	0.000824	CcSEcCtD
Asenapine—Insomnia—Methylprednisolone—ulcerative colitis	0.00016	0.000822	CcSEcCtD
Asenapine—Anaemia—Prednisone—ulcerative colitis	0.000159	0.000816	CcSEcCtD
Asenapine—Shock—Betamethasone—ulcerative colitis	0.000158	0.000814	CcSEcCtD
Asenapine—Shock—Dexamethasone—ulcerative colitis	0.000158	0.000814	CcSEcCtD
Asenapine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000158	0.000812	CcSEcCtD
Asenapine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000158	0.000811	CcSEcCtD
Asenapine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000158	0.000811	CcSEcCtD
Asenapine—Agitation—Prednisone—ulcerative colitis	0.000158	0.000811	CcSEcCtD
Asenapine—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000158	0.00081	CcSEcCtD
Asenapine—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000158	0.00081	CcSEcCtD
Asenapine—Nausea—Mesalazine—ulcerative colitis	0.000157	0.000808	CcSEcCtD
Asenapine—Tachycardia—Betamethasone—ulcerative colitis	0.000157	0.000807	CcSEcCtD
Asenapine—Tachycardia—Dexamethasone—ulcerative colitis	0.000157	0.000807	CcSEcCtD
Asenapine—Angioedema—Prednisone—ulcerative colitis	0.000157	0.000806	CcSEcCtD
Asenapine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000156	0.000802	CcSEcCtD
Asenapine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000156	0.0008	CcSEcCtD
Asenapine—Malaise—Prednisone—ulcerative colitis	0.000155	0.000796	CcSEcCtD
Asenapine—Syncope—Prednisone—ulcerative colitis	0.000154	0.000791	CcSEcCtD
Asenapine—Fatigue—Triamcinolone—ulcerative colitis	0.000153	0.000786	CcSEcCtD
Asenapine—Fatigue—Methylprednisolone—ulcerative colitis	0.000153	0.000784	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—ulcerative colitis	0.000151	0.000776	CcSEcCtD
Asenapine—Hypotension—Dexamethasone—ulcerative colitis	0.00015	0.000773	CcSEcCtD
Asenapine—Hypotension—Betamethasone—ulcerative colitis	0.00015	0.000773	CcSEcCtD
Asenapine—Convulsion—Prednisone—ulcerative colitis	0.000149	0.000764	CcSEcCtD
Asenapine—Hypertension—Prednisone—ulcerative colitis	0.000148	0.000762	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000147	0.000753	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000147	0.000753	CcSEcCtD
Asenapine—Arthralgia—Prednisone—ulcerative colitis	0.000146	0.000751	CcSEcCtD
Asenapine—Anxiety—Prednisone—ulcerative colitis	0.000146	0.000749	CcSEcCtD
Asenapine—Insomnia—Dexamethasone—ulcerative colitis	0.000146	0.000748	CcSEcCtD
Asenapine—Insomnia—Betamethasone—ulcerative colitis	0.000146	0.000748	CcSEcCtD
Asenapine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000142	0.00073	CcSEcCtD
Asenapine—Dyspepsia—Betamethasone—ulcerative colitis	0.000142	0.000728	CcSEcCtD
Asenapine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000142	0.000728	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—ulcerative colitis	0.00014	0.00072	CcSEcCtD
Asenapine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000139	0.000714	CcSEcCtD
Asenapine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000139	0.000714	CcSEcCtD
Asenapine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000139	0.000713	CcSEcCtD
Asenapine—Fatigue—Dexamethasone—ulcerative colitis	0.000139	0.000713	CcSEcCtD
Asenapine—Fatigue—Betamethasone—ulcerative colitis	0.000139	0.000713	CcSEcCtD
Asenapine—Shock—Prednisone—ulcerative colitis	0.000138	0.000708	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—ulcerative colitis	0.000137	0.000706	CcSEcCtD
Asenapine—Tachycardia—Prednisone—ulcerative colitis	0.000137	0.000703	CcSEcCtD
Asenapine—Asthenia—Hydrocortisone—ulcerative colitis	0.000135	0.000694	CcSEcCtD
Asenapine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000131	0.000671	CcSEcCtD
Asenapine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.00013	0.00067	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000128	0.000656	CcSEcCtD
Asenapine—Dizziness—Prednisolone—ulcerative colitis	0.000128	0.000655	CcSEcCtD
Asenapine—Asthenia—Triamcinolone—ulcerative colitis	0.000127	0.000654	CcSEcCtD
Asenapine—Asthenia—Methylprednisolone—ulcerative colitis	0.000127	0.000652	CcSEcCtD
Asenapine—Insomnia—Prednisone—ulcerative colitis	0.000127	0.000651	CcSEcCtD
Asenapine—Dizziness—Hydrocortisone—ulcerative colitis	0.000125	0.00064	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—ulcerative colitis	0.000123	0.000634	CcSEcCtD
Asenapine—Rash—Prednisolone—ulcerative colitis	0.000122	0.000625	CcSEcCtD
Asenapine—Dermatitis—Prednisolone—ulcerative colitis	0.000122	0.000624	CcSEcCtD
Asenapine—Fatigue—Prednisone—ulcerative colitis	0.000121	0.000621	CcSEcCtD
Asenapine—Headache—Prednisolone—ulcerative colitis	0.000121	0.000621	CcSEcCtD
Asenapine—Constipation—Prednisone—ulcerative colitis	0.00012	0.000616	CcSEcCtD
Asenapine—Vomiting—Hydrocortisone—ulcerative colitis	0.00012	0.000615	CcSEcCtD
Asenapine—Rash—Hydrocortisone—ulcerative colitis	0.000119	0.00061	CcSEcCtD
Asenapine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000119	0.00061	CcSEcCtD
Asenapine—Headache—Hydrocortisone—ulcerative colitis	0.000118	0.000606	CcSEcCtD
Asenapine—Dizziness—Triamcinolone—ulcerative colitis	0.000117	0.000603	CcSEcCtD
Asenapine—Dizziness—Methylprednisolone—ulcerative colitis	0.000117	0.000601	CcSEcCtD
Asenapine—Asthenia—Dexamethasone—ulcerative colitis	0.000116	0.000593	CcSEcCtD
Asenapine—Asthenia—Betamethasone—ulcerative colitis	0.000116	0.000593	CcSEcCtD
Asenapine—Nausea—Prednisolone—ulcerative colitis	0.000115	0.000589	CcSEcCtD
Asenapine—Vomiting—Triamcinolone—ulcerative colitis	0.000113	0.000579	CcSEcCtD
Asenapine—Vomiting—Methylprednisolone—ulcerative colitis	0.000113	0.000578	CcSEcCtD
Asenapine—Nausea—Hydrocortisone—ulcerative colitis	0.000112	0.000575	CcSEcCtD
Asenapine—Rash—Triamcinolone—ulcerative colitis	0.000112	0.000575	CcSEcCtD
Asenapine—Dermatitis—Triamcinolone—ulcerative colitis	0.000112	0.000574	CcSEcCtD
Asenapine—Rash—Methylprednisolone—ulcerative colitis	0.000112	0.000573	CcSEcCtD
Asenapine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000112	0.000573	CcSEcCtD
Asenapine—Headache—Triamcinolone—ulcerative colitis	0.000111	0.000571	CcSEcCtD
Asenapine—Headache—Methylprednisolone—ulcerative colitis	0.000111	0.00057	CcSEcCtD
Asenapine—Dizziness—Betamethasone—ulcerative colitis	0.000106	0.000547	CcSEcCtD
Asenapine—Dizziness—Dexamethasone—ulcerative colitis	0.000106	0.000547	CcSEcCtD
Asenapine—Nausea—Triamcinolone—ulcerative colitis	0.000105	0.000541	CcSEcCtD
Asenapine—Nausea—Methylprednisolone—ulcerative colitis	0.000105	0.00054	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—ulcerative colitis	0.000103	0.000531	CcSEcCtD
Asenapine—Vomiting—Dexamethasone—ulcerative colitis	0.000102	0.000526	CcSEcCtD
Asenapine—Vomiting—Betamethasone—ulcerative colitis	0.000102	0.000526	CcSEcCtD
Asenapine—Rash—Betamethasone—ulcerative colitis	0.000102	0.000521	CcSEcCtD
Asenapine—Rash—Dexamethasone—ulcerative colitis	0.000102	0.000521	CcSEcCtD
Asenapine—Dermatitis—Betamethasone—ulcerative colitis	0.000101	0.000521	CcSEcCtD
Asenapine—Dermatitis—Dexamethasone—ulcerative colitis	0.000101	0.000521	CcSEcCtD
Asenapine—Headache—Betamethasone—ulcerative colitis	0.000101	0.000518	CcSEcCtD
Asenapine—Headache—Dexamethasone—ulcerative colitis	0.000101	0.000518	CcSEcCtD
Asenapine—Asthenia—Prednisone—ulcerative colitis	0.000101	0.000517	CcSEcCtD
Asenapine—Nausea—Betamethasone—ulcerative colitis	9.56e-05	0.000491	CcSEcCtD
Asenapine—Nausea—Dexamethasone—ulcerative colitis	9.56e-05	0.000491	CcSEcCtD
Asenapine—Dizziness—Prednisone—ulcerative colitis	9.27e-05	0.000476	CcSEcCtD
Asenapine—Vomiting—Prednisone—ulcerative colitis	8.91e-05	0.000458	CcSEcCtD
Asenapine—Rash—Prednisone—ulcerative colitis	8.84e-05	0.000454	CcSEcCtD
Asenapine—Dermatitis—Prednisone—ulcerative colitis	8.83e-05	0.000454	CcSEcCtD
Asenapine—Headache—Prednisone—ulcerative colitis	8.78e-05	0.000451	CcSEcCtD
Asenapine—Nausea—Prednisone—ulcerative colitis	8.33e-05	0.000428	CcSEcCtD
Asenapine—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	8.7e-06	6.47e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	8.69e-06	6.46e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	8.57e-06	6.37e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—RELA—ulcerative colitis	8.54e-06	6.35e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—RELA—ulcerative colitis	8.54e-06	6.34e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	8.54e-06	6.34e-05	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TP53—ulcerative colitis	8.48e-06	6.3e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—RELA—ulcerative colitis	8.48e-06	6.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL2—ulcerative colitis	8.47e-06	6.29e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—STAT3—ulcerative colitis	8.44e-06	6.28e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—JAK2—ulcerative colitis	8.44e-06	6.27e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	8.35e-06	6.2e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	8.33e-06	6.19e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	8.32e-06	6.19e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL2—ulcerative colitis	8.31e-06	6.18e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—RELA—ulcerative colitis	8.3e-06	6.17e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	8.23e-06	6.12e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.18e-06	6.08e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—RELA—ulcerative colitis	8.17e-06	6.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	8.16e-06	6.06e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—ALB—ulcerative colitis	8.13e-06	6.04e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—JAK2—ulcerative colitis	8.05e-06	5.99e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CXCL8—ulcerative colitis	8.05e-06	5.99e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CXCL8—ulcerative colitis	8.04e-06	5.98e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	7.99e-06	5.94e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	7.93e-06	5.89e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TGFB1—ulcerative colitis	7.83e-06	5.82e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	7.82e-06	5.82e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—RELA—ulcerative colitis	7.8e-06	5.8e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CXCL8—ulcerative colitis	7.7e-06	5.72e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL2—ulcerative colitis	7.7e-06	5.72e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL2—ulcerative colitis	7.69e-06	5.71e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—ulcerative colitis	7.66e-06	5.69e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—ulcerative colitis	7.65e-06	5.69e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL2—ulcerative colitis	7.64e-06	5.68e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	7.6e-06	5.65e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—JAK2—ulcerative colitis	7.59e-06	5.65e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	7.58e-06	5.63e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—JAK2—ulcerative colitis	7.49e-06	5.57e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CALM3—ulcerative colitis	7.49e-06	5.57e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL2—ulcerative colitis	7.48e-06	5.56e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	7.44e-06	5.53e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL2—ulcerative colitis	7.36e-06	5.47e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—RELA—ulcerative colitis	7.36e-06	5.47e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CXCL8—ulcerative colitis	7.35e-06	5.46e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PPARG—ulcerative colitis	7.34e-06	5.46e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—ulcerative colitis	7.32e-06	5.44e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—ulcerative colitis	7.28e-06	5.41e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—ulcerative colitis	7.28e-06	5.41e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—RELA—ulcerative colitis	7.26e-06	5.39e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—ulcerative colitis	7.23e-06	5.38e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	7.23e-06	5.37e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	7.21e-06	5.36e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—NFKB1—ulcerative colitis	7.2e-06	5.35e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.16e-06	5.32e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	7.15e-06	5.32e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PTGS2—ulcerative colitis	7.11e-06	5.29e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	7.08e-06	5.26e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL2—ulcerative colitis	7.02e-06	5.22e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	7e-06	5.2e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—ulcerative colitis	6.99e-06	5.2e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—ulcerative colitis	6.96e-06	5.18e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	6.93e-06	5.15e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NFKB1—ulcerative colitis	6.89e-06	5.12e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	6.88e-06	5.11e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	6.84e-06	5.08e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	6.83e-06	5.08e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	6.77e-06	5.03e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	6.68e-06	4.96e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—ulcerative colitis	6.65e-06	4.94e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2—ulcerative colitis	6.62e-06	4.92e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—ulcerative colitis	6.62e-06	4.92e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—RELA—ulcerative colitis	6.61e-06	4.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—ulcerative colitis	6.6e-06	4.91e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—ulcerative colitis	6.59e-06	4.9e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NFKB1—ulcerative colitis	6.58e-06	4.89e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	6.55e-06	4.87e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2—ulcerative colitis	6.54e-06	4.86e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	6.53e-06	4.85e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—ulcerative colitis	6.5e-06	4.83e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	6.5e-06	4.83e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—STAT3—ulcerative colitis	6.48e-06	4.81e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—RELA—ulcerative colitis	6.47e-06	4.81e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—STAT3—ulcerative colitis	6.47e-06	4.81e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—ulcerative colitis	6.44e-06	4.79e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	6.43e-06	4.78e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.42e-06	4.77e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	6.42e-06	4.77e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—RELA—ulcerative colitis	6.33e-06	4.7e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	6.32e-06	4.7e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	6.29e-06	4.68e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	6.29e-06	4.68e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—ulcerative colitis	6.27e-06	4.66e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	6.23e-06	4.63e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	6.2e-06	4.61e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—STAT3—ulcerative colitis	6.19e-06	4.6e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—ulcerative colitis	6.19e-06	4.6e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	6.17e-06	4.59e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	6.12e-06	4.55e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	6.12e-06	4.55e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	6.1e-06	4.53e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	6e-06	4.46e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—ulcerative colitis	6e-06	4.46e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	5.96e-06	4.43e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	5.96e-06	4.43e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2—ulcerative colitis	5.96e-06	4.43e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	5.93e-06	4.41e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	5.93e-06	4.4e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—STAT3—ulcerative colitis	5.91e-06	4.39e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	5.9e-06	4.39e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—ulcerative colitis	5.9e-06	4.38e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	5.87e-06	4.36e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	5.83e-06	4.34e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	5.83e-06	4.33e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2—ulcerative colitis	5.83e-06	4.33e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	5.8e-06	4.31e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.78e-06	4.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	5.78e-06	4.29e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	5.77e-06	4.29e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—ulcerative colitis	5.74e-06	4.27e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—JAK2—ulcerative colitis	5.73e-06	4.26e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2—ulcerative colitis	5.7e-06	4.23e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	5.67e-06	4.21e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	5.67e-06	4.21e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	5.64e-06	4.19e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	5.64e-06	4.19e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	5.64e-06	4.19e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—JAK2—ulcerative colitis	5.63e-06	4.18e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	5.58e-06	4.15e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	5.58e-06	4.15e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—ulcerative colitis	5.57e-06	4.14e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RELA—ulcerative colitis	5.55e-06	4.13e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	5.53e-06	4.11e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	5.52e-06	4.11e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	5.51e-06	4.1e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	5.51e-06	4.1e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—ulcerative colitis	5.5e-06	4.09e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	5.48e-06	4.08e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—ulcerative colitis	5.48e-06	4.07e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	5.46e-06	4.06e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	5.46e-06	4.05e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RELA—ulcerative colitis	5.45e-06	4.05e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	5.44e-06	4.04e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	5.39e-06	4.01e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	5.36e-06	3.99e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	5.35e-06	3.98e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	5.33e-06	3.96e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	5.31e-06	3.94e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	5.23e-06	3.89e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	5.22e-06	3.88e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	5.17e-06	3.84e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	5.16e-06	3.84e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	5.15e-06	3.83e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	5.14e-06	3.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	5.13e-06	3.82e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	5.1e-06	3.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	5.04e-06	3.75e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	5.01e-06	3.73e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—ulcerative colitis	5e-06	3.72e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—ulcerative colitis	4.98e-06	3.7e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	4.97e-06	3.7e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	4.97e-06	3.69e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—ulcerative colitis	4.94e-06	3.67e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—ulcerative colitis	4.94e-06	3.67e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	4.92e-06	3.66e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—ulcerative colitis	4.91e-06	3.65e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—ulcerative colitis	4.9e-06	3.65e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	4.9e-06	3.64e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	4.9e-06	3.64e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—ulcerative colitis	4.89e-06	3.63e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	4.82e-06	3.58e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—ulcerative colitis	4.8e-06	3.57e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	4.79e-06	3.56e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	4.79e-06	3.56e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—ulcerative colitis	4.79e-06	3.56e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	4.77e-06	3.54e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—ulcerative colitis	4.73e-06	3.52e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—ulcerative colitis	4.73e-06	3.51e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	4.68e-06	3.48e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	4.68e-06	3.48e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	4.66e-06	3.46e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—ulcerative colitis	4.65e-06	3.45e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	4.65e-06	3.45e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	4.64e-06	3.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	4.61e-06	3.43e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	4.6e-06	3.42e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	4.6e-06	3.42e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	4.56e-06	3.39e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	4.54e-06	3.38e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—ulcerative colitis	4.52e-06	3.36e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—ulcerative colitis	4.52e-06	3.36e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	4.51e-06	3.35e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—ulcerative colitis	4.51e-06	3.35e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.5e-06	3.34e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—ulcerative colitis	4.49e-06	3.34e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	4.48e-06	3.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	4.45e-06	3.31e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	4.44e-06	3.3e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	4.42e-06	3.29e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—ulcerative colitis	4.4e-06	3.27e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—ulcerative colitis	4.33e-06	3.22e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—ulcerative colitis	4.3e-06	3.2e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	4.3e-06	3.2e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—ulcerative colitis	4.25e-06	3.16e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	4.24e-06	3.15e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—ulcerative colitis	4.21e-06	3.13e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—ulcerative colitis	4.2e-06	3.12e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.2e-06	3.12e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	4.19e-06	3.12e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	4.14e-06	3.08e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—ulcerative colitis	4.13e-06	3.07e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—ulcerative colitis	4.13e-06	3.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	4.05e-06	3.01e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.05e-06	3.01e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	3.9e-06	2.9e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—ulcerative colitis	3.89e-06	2.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—ulcerative colitis	3.84e-06	2.86e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	3.84e-06	2.85e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	3.83e-06	2.85e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—ulcerative colitis	3.82e-06	2.84e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	3.79e-06	2.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	3.77e-06	2.8e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.76e-06	2.8e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	3.76e-06	2.79e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—ulcerative colitis	3.74e-06	2.78e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—ulcerative colitis	3.66e-06	2.72e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—ulcerative colitis	3.65e-06	2.71e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	3.64e-06	2.71e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	3.54e-06	2.63e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—ulcerative colitis	3.5e-06	2.6e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	3.49e-06	2.6e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	3.47e-06	2.58e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—ulcerative colitis	3.42e-06	2.55e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—ulcerative colitis	3.35e-06	2.49e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	3.33e-06	2.48e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	3.24e-06	2.41e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—ulcerative colitis	3.21e-06	2.39e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.19e-06	2.37e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	3.16e-06	2.35e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—ulcerative colitis	3.15e-06	2.34e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.13e-06	2.33e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	3.09e-06	2.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—ulcerative colitis	2.94e-06	2.19e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	2.89e-06	2.15e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—ulcerative colitis	2.89e-06	2.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	2.88e-06	2.14e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.83e-06	2.11e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—ulcerative colitis	2.81e-06	2.09e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.63e-06	1.96e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.46e-06	1.83e-05	CbGpPWpGaD
